GSK’s Cancer Drug Jemperli Nears EU Marketing Expansion
In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...
FiercePharma12d
GSK cuts Shingrix deliveries in revised Zhifei China pact, moves closer to RSV vaccine deal
Under the revised agreement, the two have taken their RSV commitment a step forward as Zhifei agrees to engage exclusively ...
GSK, China’s Zhifei Extend Shingles Shot Collaboration to 2034
GSK extended its collaboration with Zhifei to commercialize its shingles vaccine Shingrix in China until 2034.
BioPharma Dive12d
GSK taps a startup for shot at Alzheimer’s drug
The collaboration deal, which could be worth hundreds of millions of dollars, is a “pivotal moment” for Muna Therapeutics, a ...
Wall Street Journal7d
GSK Gets Positive Results in Blood-Cancer Drug Trial
GSK’sGSK-0.34%decrease ... compared with Johnson & Johnson’s Darzalex, the British pharma giant said Monday.
The Pharma Letter12d
GSK expands vaccine collaboration in China with Zhifei
UK pharma major GSK has into an agreement with Chongqing Zhifei Biological Products (Zhifei) to revize the terms on which ...
GSK Is Doing The Right Things But Can't Catch A Break - Rating Downgrade
GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.
GSK, Relation Therapeutics Partner to Advance Osteoarthritis, Fibrotic Disease Treatments
Relation Therapeutics and GSK signed two contracts to discover and develop new therapeutic targets to treat osteoarthritis and fibrotic disease.
biopharma-reporter7d
Relation and GSK join forces to advance fibrotic diseases and osteoarthritis therapies
Big pharma company GSK and UK AI-biotech Relation Therapeutics have entered into two strategic collaborations to identify and ...
FiercePharma11d
Fierce Pharma Asia—Sanofi's $1B manufacturing base; GSK's ADC deal, Shingrix recalibration in China
Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...
GSK's Cancer Drug Jemperli Nears EU Marketing Expansion -- 2nd Update
GSK's cancer drug Jemperli cleared an important hurdle ahead of potentially expanding its European Union marketing permission, in a boost to the pharmaceutical giant's oncology pipeline.